Tag: Ofev

BI unveils new data backing IPF drug Ofev

by Selina McKee | Oct 26, 2016 | News | 0

Two new analyses of data from late-stage trials of Boehringer Ingelheim’s lung drug Ofev presented at CHEST 2016 lend further weight to the body of evidence backing its effectiveness in people with idiopathic pulmonary fibrosis.

US/EU orphan status for BI’s Ofev in systemic sclerosis

by Selina McKee | Sep 12, 2016 | News | 0

US and EU regulators have granted Orphan Drug Designation to Boehringer Ingelheim’s Ofev for the treatment of systemic sclerosis, including the associated interstitial lung disease.